DUBLIN--(BUSINESS WIRE)--The "Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation & Discovery) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period
The growth of this market is mainly driven by increasing healthcare expenditure and the increase in R&D funding. Other important factors aiding the growth of this market include the increasing utility of biomarkers for diagnostic purposes and new initiatives for biomarker research.
Moreover, the emergence of companion diagnostics (CDx) has further intensified biomarker R&D activities. However, significant capital investments are required for the discovery, development, and validation of biomarkers. This is a major factor restraining the growth of the biomarker technologies market.
The key players in this market are Agilent Technologies (US), Thermo Fisher Scientific (US), Roche (Switzerland), Waters Corporation (US), Danaher Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US).
Key Topics Covered:
1 Biomarker Technologies Market: Introduction
2 Biomarker Technologies Market: Research Methodology
3 Biomarker Technologies Market, By Test Type
4 Biomarkers Liquid Biopsy Market, By Application
5 Liquid Biopsy Market, By Technology
6 Biomarker Technologies Market, By Product
7 Biomarker Product Market, By Application
8 Biomarker Technologies Market, By Profiling Technology
9 Biomarker Profiling Technology Market, By Application
10 Biomarker Disease Indication Market, By Application
11 Biomarker Technologies Market, By Application
12 Biomarker Technology Applications Market, By Product
13 Biomarker Technologies Market, By Research Area
14 Market Share Analysis
15 Biomarker Technologies Market, By Region
- Agilent Technologies (US)
- Thermo Fisher Scientific (US)
- Roche (Switzerland)
- Waters Corporation (US)
- Danaher Corporation (US)
- Shimadzu Corporation (Japan)
- Bio-Rad Laboratories (US)
For more information about this report visit https://www.researchandmarkets.com/research/jb2z22/biomarker?w=4